Pharmaceutical development services
by Patheon Inc.
Patheon Inc. recently announced the opening of a new Pharmaceutical Development Services (PDS) facility in Swindon, UK. Complementing North American PDS operations, this new state-of-the-art facility will develop NCEs in Europe quickly and cost effectively. Offering formulation, analytical development and clinical trial manufacturing services, the new facility handles both high- and low-potency molecules across a wide range of dosage forms, including sterile products. Conveniently located within the commercial manufacturing site, PDS at Swindon offers complete and integrated solutions, seamlessly moving products from development to commercialisation.
| Published: | 2005 |
| Format: | |
| Length: | 2 pages |
| Type: | Product Collateral |
| Language: | English |
.
SPONSORED REPORTS
